MOSCOW, January 17. /TASS/. The Russian Direct Investment Fund (RDIF), a sovereign wealth fund, refuted reports that Brazil has refused to fast-track registration of Russia’s Sputnik V coronavirus vaccine, noting that the country’s regulator requested more information about the vaccine.
"Amid false information in some media reports on the refusal to fast-track registration of Sputnik V vaccine in Brazil, we inform that the Brazilian Health Regulatory Agency (Anvisa) has requested additional information about Sputnik V vaccine, which will be provided soon," RDIF said.
According to RDIF, the regulator’s request for additional information is a standard procedure and doesn’t mean the refusal from registration.
On Sunday, the Brazilian Health Regulatory Agency reported that it returned to RDIF’s partner Uniao Quimica the documents submitted for approving the Russian vaccine for emergency use in the country.
On August 11, 2020, Russia became the first in the world to register a coronavirus vaccine Sputnik V developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry. Sputnik V is an adenovirus-based vector vaccine.